United States Gastric Adenocarcinoma Epidemiology Report 2022-2042
26 mai 2023 07h18 HE
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Gastric Adenocarcinoma in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard" report has been added to ...
United States Non-Squamous Non-Small-Cell Lung Cancer Epidemiology Report 2022-2042
26 mai 2023 07h13 HE
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Non-Squamous Non-Small-Cell Lung Cancer in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard" report has been added to ...
United States Squamous-Cell Carcinoma of the Larynx Epidemiology Report 2022-2042
26 mai 2023 07h08 HE
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Squamous-Cell Carcinoma of the Larynx in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard" report has been added to ...
United States Squamous-Cell Carcinoma of the Oral Cavity Epidemiology Report 2022-2042
25 mai 2023 10h38 HE
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Squamous-Cell Carcinoma of the Oral Cavity in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard" report has been added to ...
United States Larynx Cancer Epidemiology Report 2022-2042
25 mai 2023 10h33 HE
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Larynx Cancer in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard" report has been added to ResearchAndMarkets.com's...
United States Non-Small-Cell Lung (NSCL) Cancer Epidemiology Report 2022-2042
25 mai 2023 10h13 HE
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Non-Small-Cell Lung Cancer in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard" report has been added to ...
Biodexa Pharmaceuticals PLC Announces US$3.32 Million Registered Direct Offering
24 mai 2023 08h40 HE
|
Biodexa Pharmaceuticals PLC
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH...
Posting of Annual Report & Notice of AGM
22 mai 2023 16h15 HE
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical company...
Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals
18 mai 2023 08h30 HE
|
Biodexa Pharmaceuticals PLC
18 May 2023 Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa” or the...
2023 Bispecific CD3 Molecules in Oncology Analytical Tool: Covering 67 Companies Plus Partners who are Today Developing 148 Bispecific CD3 Drugs
16 mai 2023 12h18 HE
|
Research and Markets
Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Bispecific CD3 Molecules in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.There is a considerable and robust...